Operating Lease, Payments in USD of Y-mAbs Therapeutics, Inc. from Q1 2019 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Y-mAbs Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2025.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2025 was $244K, a 2.79% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Payments for the twelve months ending March 31, 2025 was $982K, a 6.39% decline year-over-year.
  • Y-mAbs Therapeutics, Inc. annual Operating Lease, Payments for 2024 was $989K, a 6.43% decline from 2023.
  • Y-mAbs Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $1.06M, a 53.8% decline from 2022.
  • Y-mAbs Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $2.29M, a 3.16% increase from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)

Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $982K $244K -$7K -2.79% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $989K $246K -$20K -7.52% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-04
Q3 2024 $1.01M $247K -$19K -7.14% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $1.03M $245K -$21K -7.9% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.05M $251K -$8K -3.09% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $1.06M $266K -$331K -55.4% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-04
Q3 2023 $1.39M $266K -$215K -44.7% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $1.6M $266K -$335K -55.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $1.94M $259K -$348K -57.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $2.29M $597K +$22K +3.83% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $2.26M $481K -$67K -12.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $2.33M $601K +$52K +9.47% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $2.28M $607K +$63K +11.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $2.22M $575K -$79K -12.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-30
Q3 2021 $2.3M $548K +$347K +173% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $1.95M $549K +$344K +168% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $1.6M $544K +$356K +189% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.25M $654K +$468K +252% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $780K $201K +$13K +6.92% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $767K $205K +$5K +2.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $762K $188K +$156K +488% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $606K $186K Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $188K Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $200K Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $32K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07

Y-mAbs Therapeutics, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $989K -$68K -6.43% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-04
2023 $1.06M -$1.23M -53.8% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-04
2022 $2.29M +$70K +3.16% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 $2.22M +$968K +77.6% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $1.25M +$642K +106% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $606K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.